Antisense Treatment of ALS

Medical Intelligence; Current Concepts - Sialorrhea
Richard Alan Smith, M.D.; Richard L. Goode, M.D.

On Behalf of the Patient
R.A. Smith

Amyotrophic Lateral Sclerosis and History of Skeletal Fracture: A Case-Control Study
Louis S. Gresham, MPH; Amanda L. Golbeck, PhD; Richard Smith, MD

Recombinant Growth Hormone Treatment of Amyotrophic Lateral Sclerosis
R.A. Smith, MD; S. Melmed, MD; B. Sherman, MD; J. Frane, PhD; T.L. Munsat, MD; B.W. Festoff, MD

Amyotrophic Lateral Sclerosis and Occupational Heavy Metal Exposure: A Case-Control Study
Louis S. Gresham; Craig A. Molgaard; Richard Smith

Palliative Treatment of Motor Neuron Disease
Richard Alan Smith; Ellen Gillie; Jonathan Licht

Figure 3
Flow volume loop in sitting (a), and supnic (b) Positions. Note the mark decrease in vital capacity from 2.46 to 1.42 Liters as well as the decrease in the flows and size of the loop.

The Exitotoxin Hypothesis: Therapeutic Considerations In Amyotrophic Lateral Sclerosis
Richard A. Smith; Kristen L. Valderhaug; Peter J. Wedlund

Testing the Limits Of Palliative Care
Richard A. Smith; Jonathan M. Licht; Peter E Manley; Beverly Girten; Ron Tuttle

NOTE: All of the files were saved as standard ACSII text format. When viewing these files, you will notice that there are spelling errors due to scanner text recognition. If you do find an error, please report it to CNS.